Shiqiang Liu

Title: Shiqiang Liu: Innovator in Cancer Treatment

Introduction

Shiqiang Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various types of cancer. His innovative work has led to the creation of a patent that addresses critical health challenges.

Latest Patents

Shiqiang Liu holds a patent for "Nitrogen-containing heterocyclic derivatives, method therefor and application therefor as inhibitors of KRAS G12C for the treatment of cancers." This patent discloses a nitrogen-containing heterocyclic derivative regulator, a preparation method, and its application as a KRAS G12C mutation inhibitor. The compound is particularly useful in treating diseases such as leukemia, neuroblastoma, melanoma, breast cancer, lung cancer, and colon cancer.

Career Highlights

Throughout his career, Shiqiang Liu has worked with notable companies, including Jiangsu Hansoh Pharmaceutical Group Co., Ltd. and Shanghai Hansoh Biomedical Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Shiqiang Liu has collaborated with esteemed colleagues, including Rudi Bao and Yongsheng Wang. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Shiqiang Liu's work in the field of cancer treatment exemplifies the impact of innovation in pharmaceuticals. His contributions through patents and collaborations highlight the importance of research in addressing critical health issues.